Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3K citations

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +7

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells

Paola Panina‐Bordignon, Agnes L. Tan, A. Termijtelen et al. · European Journal of Immunology · 1989 · 707 citations

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

Alain C. Tissot, Patrik Maurer, Juerg Nussberger et al. · The Lancet · 2008 · 284 citations

Hypertension, Angiotensin Ii, Cardiovascular Disease +8

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

Patrice M. Ambühl, Alain C. Tissot, Alma Fulurija et al. · Journal of Hypertension · 2006 · 218 citations